Contact
searchSearch
HMP Global

July 2017 - FRMC

Conference Insider
Medicare Advantage Members Experience More Adherence-Related Problems
07/31/2017
Medicare Advantage prescription drug plan members experience more medication-related problems, such as problems with adherence, when compared to other prescription drug plan members, according to a poster presented at ASHP’s 2017 Summer...
Medicare Advantage prescription drug plan members experience more medication-related problems, such as problems with adherence, when compared to other prescription drug plan members, according to a poster presented at ASHP’s 2017 Summer...
Medicare Advantage prescription...
07/31/2017
First Report Managed Care
Department
Pharmacist-Physician Integration Crucial to Comprehensive Medication Management
07/31/2017
A poster presented at the ASHP’s 2017 Summer Meetings and Exhibition outlined the strategies crucial to a successful pharmacist-physician integrated comprehensive medication management (CMM) program.
A poster presented at the ASHP’s 2017 Summer Meetings and Exhibition outlined the strategies crucial to a successful pharmacist-physician integrated comprehensive medication management (CMM) program.
A poster presented at the ASHP’s...
07/31/2017
First Report Managed Care
Conference Insider
Formularies Should Reflect How Copays Impact Diabetes Drug Adherence
07/31/2017
A study presented at the American Diabetes Association’s 77th Scientific Sessions found that the impact diabetes drug copays have on patients vary widely between generic and branded products.
A study presented at the American Diabetes Association’s 77th Scientific Sessions found that the impact diabetes drug copays have on patients vary widely between generic and branded products.
A study presented at the...
07/31/2017
First Report Managed Care
Conference Insider
ACA Improved Quality of Life for Diabetes Patients
07/31/2017
After implementation of the Affordable Care Act, health related quality of life was higher among adult patients with type 2 diabetes, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
After implementation of the Affordable Care Act, health related quality of life was higher among adult patients with type 2 diabetes, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
After implementation of the...
07/31/2017
First Report Managed Care
Conference Insider
Professional Continuous Glucose Monitoring Could Cut Costs for IDNs
07/31/2017
According to recent research presented at the American Diabetes Association’s 77th Scientific Sessions, adopting a professional continuous glucose monitoring could significantly improve diabetes management and cut per-patients costs for...
According to recent research presented at the American Diabetes Association’s 77th Scientific Sessions, adopting a professional continuous glucose monitoring could significantly improve diabetes management and cut per-patients costs for...
According to recent research...
07/31/2017
First Report Managed Care
Conference Insider
SMBG Fails to Improve Type 2 Diabetes Management
07/31/2017
Recent research presented at the American Diabetes Association’s 77th Scientific Sessions showed that patients with type 2 diabetes who self-monitored blood glucose levels failed to improve glycemic control.
Recent research presented at the American Diabetes Association’s 77th Scientific Sessions showed that patients with type 2 diabetes who self-monitored blood glucose levels failed to improve glycemic control.
Recent research presented at the...
07/31/2017
First Report Managed Care
Conference Insider
Oral, Subcutaneous Insulin Demonstrate Similar Efficacy
07/31/2017
A presentation at the American Diabetes Association’s 77th Scientific Sessions showed that oral insulin achieved similar HbA1c and fasting plasma glucose levels in patients with type 2 diabetes compared with subcutaneous insulin injections.
A presentation at the American Diabetes Association’s 77th Scientific Sessions showed that oral insulin achieved similar HbA1c and fasting plasma glucose levels in patients with type 2 diabetes compared with subcutaneous insulin injections.
A presentation at the American...
07/31/2017
First Report Managed Care
Conference Insider
Single-Shot Xultophy Outperforms Basal-Bolus Insulin Regimen for Type 2 Diabetes
07/31/2017
New clinical trial data presented at the American Diabetes Association’s 77th Scientific Sessions showed that a once-daily shot of Xultophy100/3.6 (insulin degludec and liraglutide injection; Novo Nordisk) was more effective and less costly...
New clinical trial data presented at the American Diabetes Association’s 77th Scientific Sessions showed that a once-daily shot of Xultophy100/3.6 (insulin degludec and liraglutide injection; Novo Nordisk) was more effective and less costly...
New clinical trial data...
07/31/2017
First Report Managed Care
Conference Insider
Studies Confirm Biologic DMARDs Do Not Increase Cancer Risk
07/31/2017
Two studies presented at the 2017 EULAR Congress confirmed that biologic disease- modifying anti-rheumatic drugs (DMARDs), including anti-TNF treatments, do not increase the risk of cancer in patients with RA.
Two studies presented at the 2017 EULAR Congress confirmed that biologic disease- modifying anti-rheumatic drugs (DMARDs), including anti-TNF treatments, do not increase the risk of cancer in patients with RA.
Two studies presented at the...
07/31/2017
First Report Managed Care
Conference Insider
New Osteoporosis Drug Developments Offer Solutions for Postmenopausal Women
07/31/2017
A number of studies presented at the 2017 EULAR Congress highlighted recent advancements in existing drug classes and new drug classes for the treatment of osteoporosis in postmenopausal women.  
A number of studies presented at the 2017 EULAR Congress highlighted recent advancements in existing drug classes and new drug classes for the treatment of osteoporosis in postmenopausal women.  
A number of studies presented at...
07/31/2017
First Report Managed Care
Conference Insider
Cardiovascular Risks in RA Patients Declined Over Past 15 Years
07/31/2017
A recent study presented at the 2017 EULAR Congress found that the risk for cardiovascular events has decreased among patients with rheumatoid arthritis (RA) since the year 2000. 
A recent study presented at the 2017 EULAR Congress found that the risk for cardiovascular events has decreased among patients with rheumatoid arthritis (RA) since the year 2000. 
A recent study presented at the...
07/31/2017
First Report Managed Care
Department
Early Therapeutic Intervention Significantly Cuts RA Risks
07/31/2017
A presentation at the 2017 EULAR Congress found that early therapeutic intervention in patients with “pre-RA” significantly cuts down on the risk of developing moderate to severe RA.
A presentation at the 2017 EULAR Congress found that early therapeutic intervention in patients with “pre-RA” significantly cuts down on the risk of developing moderate to severe RA.
A presentation at the 2017 EULAR...
07/31/2017
First Report Managed Care
Conference Insider
New Relapse Prediction Tool Could Cut RA Costs
07/31/2017
A study presented at the 2017 EULAR Congress showed that using two measurements can accurately predict relapse risk among RA, allowing physicians to adjust dosing of disease-modifying antirheumatic drugs (DMARDs). This new prediction tool...
A study presented at the 2017 EULAR Congress showed that using two measurements can accurately predict relapse risk among RA, allowing physicians to adjust dosing of disease-modifying antirheumatic drugs (DMARDs). This new prediction tool...
A study presented at the 2017...
07/31/2017
First Report Managed Care
News Connection
Senate Unveils Revised ACA Repeal Bill, the Better Care Reconciliation Act
07/31/2017
After more than a month of tight-lipped deliberations, Senate Republicans finally unveiled their revised version of the American Health Care Act (AHCA)—known as the Better Care Reconciliation Act (BCRA), which will repeal many aspects of the...
After more than a month of tight-lipped deliberations, Senate Republicans finally unveiled their revised version of the American Health Care Act (AHCA)—known as the Better Care Reconciliation Act (BCRA), which will repeal many aspects of the...
After more than a month of...
07/31/2017
First Report Managed Care
News
Drug Prices: Could Taxing Sharp Increases Impact Costs?
07/07/2017
Paul Nicolaus
Industry stakeholders and lawmakers are desperately exploring ways to curb future drug prince increases. Experts weigh in on a recent proposal to heavily tax pharmaceutical companies when they drastically increase prices. 
Industry stakeholders and lawmakers are desperately exploring ways to curb future drug prince increases. Experts weigh in on a recent proposal to heavily tax pharmaceutical companies when they drastically increase prices. 
Industry stakeholders and...
07/07/2017
First Report Managed Care
News
Abuse-Deterrent Opioids: High Costs and Vague Outcomes Hurt Uptake
07/07/2017
Mary Beth Nierengarten
With all stakeholders looking for a solution to the opioid misuse epidemic, some have pointed to abuse-deterrent formulations as a possible solution; however, their high costs and lack of sufficient real-world efficacy have prevented...
With all stakeholders looking for a solution to the opioid misuse epidemic, some have pointed to abuse-deterrent formulations as a possible solution; however, their high costs and lack of sufficient real-world efficacy have prevented...
With all stakeholders looking...
07/07/2017
First Report Managed Care
News
Enhanced MTM: Aligning and Incentivizing to Improve Outcomes
07/05/2017
Dean Celia
MTM programs have been found to fall short, but CMS is hoping that a pilot program underway this year will—through better integration and improved communication—make an impactful difference. 
MTM programs have been found to fall short, but CMS is hoping that a pilot program underway this year will—through better integration and improved communication—make an impactful difference. 
MTM programs have been found to...
07/05/2017
First Report Managed Care
Department
Overkill: High Cost Drugs for Common Condition
07/03/2017
Russell J. Spjut, PharmD
Complex, curative agents have been a godsend for debilitating chronic disease states; however, trends indicate that development of these high-priced drugs for common conditions could have an negative effect.
Complex, curative agents have been a godsend for debilitating chronic disease states; however, trends indicate that development of these high-priced drugs for common conditions could have an negative effect.
Complex, curative agents have...
07/03/2017
First Report Managed Care
Managed Care Q&A
Fighting Opioid Misuse With Advanced Management
07/03/2017
David Costill
Snezana Mahon, PharmD, vice president, clinical product development at Express Scripts, discusses the design of Express Scripts' opioid solution.
Snezana Mahon, PharmD, vice president, clinical product development at Express Scripts, discusses the design of Express Scripts' opioid solution.
Snezana Mahon, PharmD, vice...
07/03/2017
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consul...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, h...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
Interview
Key Pharmaceutical Pipeline Developments: Insights from Industry Experts
05/29/2024
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs...
05/29/2024
First Report Managed Care
News
‘Hidden’ Signs May Signal Subclinical Progression in Early MS
07/15/2024
Jolynn Tumolo
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates and magnetic resonance imaging (MRI) lesion activity to track disease progression in patients with early multiple sclerosis (MS) may miss indicators of subclinical disease activity, with important implications...
Focusing solely on relapse rates...
07/15/2024
First Report Managed Care

July 2017 Volume 14 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use